Recombinant Escherichia coli Argininosuccinate synthase (argG)

Shipped with Ice Packs
In Stock

Description

Enzymatic Properties and Function

Structure:

  • Encoded by the argG gene (EC 6.3.4.5) .

  • Monomeric molecular weight: ~16.5 kDa; native hexameric form: ~98 kDa .

  • Contains conserved active-site residues for substrate binding and catalysis .

Catalytic Activity:

  • Converts citrulline + aspartate → argininosuccinate + ATP → ADP + phosphate .

  • Specific activity: 500 mU/mg (measured under optimal pH and temperature) .

Regulation:

  • Controlled by the arginine repressor (ArgR), which binds L-arginine to autoregulate argG transcription .

  • Operates as the rate-limiting enzyme in arginine biosynthesis .

Heterologous Expression and Acid Stress Resistance

Heterologous expression of argG from Oenococcus oeni in Lactobacillus plantarum significantly enhanced acid tolerance:

ParameterRecombinant Strain (pMG36e argG)Control Strain (pMG36e)
ASS activity at pH 3.7260% increase61% decrease
Intracellular arginine2.3-fold higherBaseline levels
Survival at pH 3.789% viability42% viability

This acid resistance was attributed to upregulated ADI pathway genes (argF, argH) and elevated ATP levels .

Temperature-Sensitive Variants for Metabolic Engineering

Error-prone PCR generated 90 ArgG variants, enabling dynamic control of citrulline production in E. coli:

  • 69% of variants showed auxotrophy at 42°C but prototrophy at 30°C .

  • The ArgG-G9 variant allowed precise growth regulation:

    • Citrulline yield: 4.2 g/L at 30°C vs. 0.8 g/L at 42°C .

Recombinant Protein Production Systems

  • Vector design: pMB1’ origin (500–700 copies/cell) outperformed p15A (10 copies/cell) in protein yield .

  • Inducible promoters: T7 and tetR-regulated systems enhanced ArgG expression 11-fold under stress .

Metabolic Burden Analysis

Proteomic profiling of E. coli expressing recombinant ArgG revealed:

  • Upregulated pathways: Amino acid biosynthesis (arginine, glutamate), nucleotide metabolism .

  • Downregulated pathways: Carbon metabolism, stress response proteins .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
argG; ECDH10B_3346Argininosuccinate synthase; EC 6.3.4.5; Citrulline--aspartate ligase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-447
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli (strain K12 / DH10B)
Target Names
argG
Target Protein Sequence
MTTILKHLPV GQRIGIAFSG GLDTSAALLW MRQKGAVPYA YTANLGQPDE EDYDAIPRRA MEYGAENARL IDCRKQLVAE GIAAIQCGAF HNTTGGLTYF NTTPLGRAVT GTMLVAAMKE DGVNIWGDGS TYKGNDIERF YRYGLLTNAE LQIYKPWLDT DFIDELGGRH EMSEFMIACG FDYKMSVEKA YSTDSNMLGA THEAKDLEYL NSSVKIVNPI MGVKFWDESV KIPAEEVTVR FEQGHPVALN GKTFSDDVEM MLEANRIGGR HGLGMSDQIE NRIIEAKSRG IYEAPGMALL HIAYERLLTG IHNEDTIEQY HAHGRQLGRL LYQGRWFDSQ ALMLRDSLQR WVASQITGEV TLELRRGNDY SILNTVSENL TYKPERLTME KGDSVFSPDD RIGQLTMRNL DITDTREKLF GYAKTGLLSS SAASGVPQVE NLENKGQ
Uniprot No.

Target Background

Database Links
Protein Families
Argininosuccinate synthase family, Type 2 subfamily
Subcellular Location
Cytoplasm.

Q&A

What is argininosuccinate synthetase (ArgG) and what is its function in E. coli?

Argininosuccinate synthetase (EC 6.3.4.5), encoded by the argG gene, catalyzes the penultimate step in the arginine biosynthetic pathway in Escherichia coli. The enzyme specifically mediates the ATP-dependent condensation of citrulline and aspartate to form argininosuccinate. This reaction is critical for de novo arginine synthesis, an essential amino acid required for protein production and various cellular processes.

Citrulline + Aspartate + ATP → Argininosuccinate + AMP + PPi

In the broader context of cellular metabolism, ArgG functions as the seventh enzyme in an eight-step pathway that converts glutamate to arginine in prokaryotes . This position makes it a potential control point for regulating arginine biosynthesis.

What is the molecular structure and characteristics of E. coli ArgG?

E. coli argininosuccinate synthetase has a molecular weight of approximately 44 kDa, consistent with the predicted size derived from its amino acid sequence . The protein contains several highly conserved regions that are crucial for its function.

The most significant structural features include:

  • Two conserved motifs (AHGCTGKGN and RAGAQGVGR) that function as ATP-binding sites, corresponding to two of the three conserved regions found in all known argininosuccinate synthetases .

  • Another conserved region, LAYSGGLDTTVAI, within the amino terminus of the protein, though its specific function remains to be fully characterized .

  • An active site architecture that enables the coordination of three substrates: citrulline, aspartate, and ATP.

Comparative sequence analysis shows varying degrees of identity with argininosuccinate synthetases from other species, reflecting evolutionary divergence while maintaining functional conservation of catalytic domains .

How is the argG gene organized in the E. coli genome?

In Escherichia coli, the argG gene exists as a discrete genetic unit scattered around the chromosome, separate from other arginine biosynthetic genes. This organization differs significantly from the clustered arrangement seen in many other bacterial species .

A comparative analysis of arginine biosynthetic gene organization across bacterial species reveals:

  • In E. coli: The argG gene is scattered around the chromosome, separate from the argECBH and carAB gene clusters .

  • In Mycobacterium tuberculosis and Streptomyces clavuligerus: The genes are clustered in the order of argCJBDFRGH and argCJBDFGH, respectively .

  • In Corynebacterium glutamicum: A clustered organization of argCJBDF has been reported .

This differential organization likely reflects distinct evolutionary paths and regulatory mechanisms across bacterial species, with implications for the coordination of arginine biosynthesis with other metabolic pathways.

What expression systems are commonly used for recombinant E. coli ArgG production?

Several expression systems have been successfully employed for recombinant production of E. coli ArgG in laboratory settings:

  • Low-copy plasmids: Systems utilizing the pSC101 origin of replication, such as pTS036-argG, provide stable, moderate-level expression suitable for complementation studies .

  • Inducible promoter systems: The tetR-inducible promoter (pLetO-1) coupled with strong ribosome binding sites enables controlled expression that can be initiated at specific growth phases .

  • pET expression system: For high-level production and purification, the T7 promoter-based pET system allows IPTG-inducible expression, typically incorporating N-terminal His-tags for affinity purification .

  • pCA24N backbone: Vectors from the ASKA library have been used for ArgG expression, providing standardized expression conditions .

The choice of expression system depends on the research objectives. For functional studies and complementation assays, low to moderate expression levels are preferable to avoid metabolic burden and protein aggregation. For biochemical characterization, higher expression levels with affinity tags facilitate purification.

How can recombinant E. coli ArgG be purified for laboratory studies?

A methodological approach for purifying recombinant E. coli ArgG typically follows these steps:

  • Expression construct design:

    • Clone the argG gene into an expression vector with an N-terminal His-tag

    • Transform into an appropriate E. coli expression strain

  • Culture conditions:

    • Grow cells in rich media such as Terrific Broth (TB)

    • Incubate at 37°C until OD600 reaches approximately 0.6

    • Induce protein expression with the appropriate inducer

  • Cell harvesting and lysis:

    • Collect cells by centrifugation

    • Resuspend in lysis buffer containing protease inhibitors

    • Disrupt cells by sonication, French press, or commercial lysis reagents

  • Purification steps:

    • Clarify lysate by centrifugation (typically 15,000-20,000 × g for 30 minutes)

    • Apply supernatant to Ni-NTA or similar IMAC resin

    • Wash with buffer containing low imidazole to remove non-specifically bound proteins

    • Elute ArgG with buffer containing higher imidazole concentrations (200-300 mM)

  • Further purification (if needed):

    • Size exclusion chromatography for higher purity

    • Ion exchange chromatography to separate charge variants

  • Quality assessment:

    • SDS-PAGE to verify purity and molecular weight (expected ~44 kDa)

    • Enzymatic activity assay to confirm functionality

    • Protein concentration determination (Bradford or BCA assay)

This protocol yields purified ArgG suitable for enzymatic characterization, structural studies, or other biochemical analyses.

How can temperature-sensitive variants of E. coli ArgG be developed?

Developing temperature-sensitive variants of E. coli ArgG requires a systematic approach combining random mutagenesis with high-throughput screening:

  • Mutagenesis strategy:

    • Perform error-prone PCR on the argG gene to introduce random mutations

    • Adjust mutagenesis conditions to control mutation frequency (typically 1-3 mutations per gene)

    • Create a library of variants in an appropriate expression vector

  • High-throughput screening system:

    • Transform the library into an argG deletion strain (ΔargG)

    • Use a fluorescent TIMER protein as a reporter for temperature-sensitive growth

    • Employ flow cytometry to enrich for variants with differential growth properties at different temperatures

  • Selection protocol:

    • Grow transformants at permissive temperature (30°C) on minimal media without arginine

    • Replicate plate to restrictive temperature (42°C)

    • Select colonies that grow at 30°C but not at 42°C

  • Validation and characterization:

    • Confirm temperature sensitivity through growth curve analysis at different temperatures

    • Verify that strains are auxotrophic for arginine at 42°C but prototrophic at 30°C

    • Sequence selected variants to identify the causative mutations

This approach has been demonstrated to be highly effective, with research showing that 90% of the selected strains exhibited temperature-sensitive growth, and 69% were specifically auxotrophic for arginine at 42°C while remaining prototrophic at 30°C .

How can ArgG be used to control citrulline production in E. coli?

Temperature-sensitive ArgG variants provide a powerful tool for dynamically controlling citrulline production in E. coli through the following methodological approach:

  • Strain engineering:

    • Generate an E. coli strain with a feedback-dysregulated arginine pathway to enhance flux to citrulline

    • Replace the native argG gene with a temperature-sensitive variant

    • Ensure the strain has the necessary genetic background for efficient citrulline production

  • Bioprocess design:

    • Implement a two-phase cultivation strategy:

      • Growth phase: Cultivate at permissive temperature (30°C) to allow arginine biosynthesis and biomass accumulation

      • Production phase: Shift to restrictive temperature (42°C) to inactivate ArgG

  • Metabolic consequences:

    • At restrictive temperature, the temperature-sensitive ArgG becomes non-functional

    • This blocks the conversion of citrulline to argininosuccinate

    • Citrulline accumulates as the pathway is blocked at the ArgG step

    • Cells eventually cease growth due to arginine auxotrophy

  • Fine-tuning production:

    • Adjust intermediate temperatures (35-40°C) to modulate ArgG activity

    • This allows for precise control of the balance between growth and citrulline production

    • Monitor both biomass formation and citrulline accumulation to optimize the process

This approach has been demonstrated in research with feedback-dysregulated E. coli strains, showing that temperature-sensitive ArgG variants enable precise and tunable control of citrulline overproduction and cell growth .

What are the structural determinants of ArgG temperature sensitivity?

The structural determinants of temperature sensitivity in ArgG variants likely involve several molecular features that affect protein stability and function:

Understanding these structural determinants provides fundamental insights into protein thermostability and enables rational design of temperature-sensitive variants with precisely tuned properties for metabolic engineering applications.

How can flow cytometry be used for ArgG variant selection?

Flow cytometry offers a powerful high-throughput method for selecting ArgG variants with specific properties, particularly temperature sensitivity. The methodological approach involves:

  • Reporter system design:

    • Construct a system where ArgG function is coupled to a fluorescent reporter

    • Use a fluorescent TIMER protein that changes its spectral properties based on protein age or stress conditions

    • Design the system so that ArgG function (or dysfunction) creates a detectable fluorescence pattern

  • Library screening protocol:

    • Transform an argG deletion strain with a library of argG variants

    • Grow cells at permissive temperature (30°C) to early log phase

    • Split the culture and shift one portion to restrictive temperature (42°C)

    • Incubate both cultures for sufficient time to allow fluorescent protein expression and maturation

  • Flow cytometry setup:

    • Analyze cells from both temperature conditions

    • Set gates to identify populations with differential fluorescence patterns between temperatures

    • Sort cells meeting the desired criteria directly into growth media

  • Validation and characterization:

    • Recover sorted cells by plating on appropriate media

    • Screen individual colonies for temperature-sensitive growth

    • Verify ArgG function through complementation or enzymatic assays

    • Sequence confirmed variants to identify mutations

  • Data analysis:

    • Compare fluorescence profiles across temperature conditions

    • Quantify the degree of temperature sensitivity

    • Correlate fluorescence patterns with growth phenotypes

This approach enables the rapid screening of thousands to millions of variants, dramatically accelerating the identification of ArgG variants with desired properties compared to traditional plate-based screening methods .

What computational approaches can predict ArgG mutations with desired properties?

Computational methods offer powerful approaches to predict ArgG mutations that may confer desired properties, such as temperature sensitivity or altered catalytic activity:

  • Structural analysis and molecular dynamics:

    • Generate homology models or use available crystal structures

    • Perform molecular dynamics simulations at different temperatures

    • Identify regions with high flexibility or temperature-sensitive conformational changes

    • Calculate energetic contributions of specific residues to protein stability

  • Protein engineering algorithms:

    • Use tools like Rosetta, FoldX, or CUPSAT to predict stability changes upon mutation

    • Calculate ΔΔG values to quantify the impact of mutations on folding energy

    • For temperature-sensitive variants, look for mutations predicted to cause moderate destabilization

  • Machine learning approaches:

    • Develop models trained on existing enzyme variant data

    • Use sequence features, structural parameters, and evolutionary information as inputs

    • Predict properties like temperature sensitivity, activity, or substrate specificity

  • Evolutionary analysis:

    • Perform multiple sequence alignments of ArgG from diverse species

    • Identify conserved vs. variable positions

    • Compare sequences from organisms with different temperature optima

    • Apply statistical coupling analysis to detect co-evolving residues

  • Implementation methodology:

    • Prioritize mutations based on predictions from multiple computational approaches

    • Design focused libraries around high-confidence predictions

    • Use combinatorial approaches to test interactions between mutations

    • Iterate between computational prediction and experimental validation

These computational approaches significantly reduce the experimental search space and guide rational design efforts, enabling more efficient development of ArgG variants with specific properties for research and biotechnological applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.